IntroMedic Balance Sheet Health
Financial Health criteria checks 6/6
IntroMedic has a total shareholder equity of ₩49.8B and total debt of ₩8.1B, which brings its debt-to-equity ratio to 16.3%. Its total assets and total liabilities are ₩62.2B and ₩12.3B respectively.
Key information
16.3%
Debt to equity ratio
₩8.14b
Debt
| Interest coverage ratio | n/a |
| Cash | ₩13.06b |
| Equity | ₩49.82b |
| Total liabilities | ₩12.34b |
| Total assets | ₩62.16b |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: A150840's short term assets (₩37.2B) exceed its short term liabilities (₩11.2B).
Long Term Liabilities: A150840's short term assets (₩37.2B) exceed its long term liabilities (₩1.1B).
Debt to Equity History and Analysis
Debt Level: A150840 has more cash than its total debt.
Reducing Debt: A150840's debt to equity ratio has reduced from 72.3% to 16.3% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: A150840 has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: A150840 has sufficient cash runway for 2.6 years if free cash flow continues to reduce at historical rates of 5.5% each year.